- Report
- December 2024
- 175 Pages
Global
From €4775EUR$5,000USD£3,993GBP
- Report
- May 2024
- 135 Pages
Global
From €6207EUR$6,499USD£5,190GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1194EUR$1,250USD£998GBP
- Report
- February 2024
- 113 Pages
Global
From €4536EUR$4,750USD£3,794GBP
- Report
- April 2023
- 89 Pages
Global
From €3500EUR$3,926USD£3,029GBP
- Report
- March 2025
- 50 Pages
Global
From €2531EUR$2,650USD£2,116GBP
Pimozide is a drug used to treat a variety of mental health conditions, including schizophrenia, Tourette's syndrome, and bipolar disorder. It is classified as an antipsychotic medication and works by blocking dopamine receptors in the brain. Pimozide is typically prescribed when other antipsychotics have not been effective. It is available in both oral and injectable forms.
Common side effects of Pimozide include drowsiness, dry mouth, constipation, and weight gain. More serious side effects can include an irregular heartbeat, seizures, and an increased risk of stroke. Pimozide should not be used in combination with certain other medications, including certain antibiotics and antifungals.
The Pimozide market is a subset of the larger Central Nervous System Drugs market. It is a highly competitive market, with many different companies offering their own versions of the drug. Companies in the Pimozide market include Novartis, Pfizer, and Mylan. Show Less Read more